Literature DB >> 26304919

Complex Type 2 Reactions in Three Patients with Hansen's Disease from a Southern United States Clinic.

Kristoffer E Leon1, Jorge L Salinas1, Robert W McDonald1, Anandi N Sheth1, Jessica K Fairley2.   

Abstract

In non-endemic countries, leprosy, or Hansen's disease (HD), remains rare and is often underrecognized. Consequently, the literature is currently lacking in clinical descriptions of leprosy complications in the United States. Immune-mediated inflammatory states known as reactions are common complications of HD. Type 1 reactions are typical of borderline cases and occur in 30% of patients and present as swelling and inflammation of existing skin lesions, neuritis, and nerve dysfunction. Type 2 reactions are systemic events that occur at the lepromatous end of the disease spectrum, and typical symptoms include fever, arthralgias, neuritis, and classic painful erythematous skin nodules known as erythema nodosum leprosum. We report three patients with lepromatous leprosy seen at a U.S. HD clinic with complicated type 2 reactions. The differences in presentations and clinical courses highlight the complexity of the disease and the need for increased awareness of unique manifestations of lepromatous leprosy in non-endemic areas. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26304919      PMCID: PMC4703255          DOI: 10.4269/ajtmh.15-0052

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  32 in total

1.  THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS.

Authors:  J SHESKIN
Journal:  Clin Pharmacol Ther       Date:  1965 May-Jun       Impact factor: 6.875

2.  Global leprosy situation, 2012.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2012-08-24

3.  Treatment of erythema nodosum leprosum with thalidomide.

Authors:  L Levy; P Fasal; N E Levan; R I Freedman
Journal:  Lancet       Date:  1973-08-11       Impact factor: 79.321

Review 4.  Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions.

Authors:  Davey P Legendre; Christina A Muzny; Edwin Swiatlo
Journal:  Pharmacotherapy       Date:  2012-01       Impact factor: 4.705

5.  Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.

Authors:  R Rattan; V Shanker; G R Tegta; G K Verma
Journal:  Indian J Lepr       Date:  2009 Oct-Dec

Review 6.  Leprosy type 1 (reversal) reactions and their management.

Authors:  Stephen L Walker; Diana N J Lockwood
Journal:  Lepr Rev       Date:  2008-12       Impact factor: 0.537

7.  Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions.

Authors:  E A Silva; A Iyer; S Ura; J R Lauris; B Naafs; P K Das; F Vilani-Moreno
Journal:  Trop Med Int Health       Date:  2007-12       Impact factor: 2.622

Review 8.  The role of thalidomide in the management of erythema nodosum leprosum.

Authors:  Steven L Walker; Michael F R Waters; Diana N J Lockwood
Journal:  Lepr Rev       Date:  2007-09       Impact factor: 0.537

9.  Transmission of leprosy: a study of skin and nasal secretions of household contacts of leprosy patients using PCR.

Authors:  Charles K Job; Joseph Jayakumar; Michael Kearney; Thomas P Gillis
Journal:  Am J Trop Med Hyg       Date:  2008-03       Impact factor: 2.345

10.  Hepatic morphology in reactional states of leprosy.

Authors:  J K Patnaik; P K Saha; S K Satpathy; B S Das; T K Bose
Journal:  Int J Lepr Other Mycobact Dis       Date:  1989-06
View more
  3 in total

1.  Late-onset ulnar neuritis following treatment of lepromatous leprosy infection.

Authors:  Trevor Wellington; Christina Schofield
Journal:  PLoS Negl Trop Dis       Date:  2019-08-19

2.  Mycobacterium leprae transmission characteristics during the declining stages of leprosy incidence: A systematic review.

Authors:  Thomas Hambridge; Shri Lak Nanjan Chandran; Annemieke Geluk; Paul Saunderson; Jan Hendrik Richardus
Journal:  PLoS Negl Trop Dis       Date:  2021-05-26

3.  Rationale use of Thalidomide in erythema nodosum leprosum - A non-systematic critical analysis of published case reports.

Authors:  Pugazhenthan Thangaraju; Sajitha Venkatesan; Meenalotchini Gurunthalingam; Shoban Babu; Tamilselvan T
Journal:  Rev Soc Bras Med Trop       Date:  2020-09-11       Impact factor: 1.581

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.